CLINICAL AND PATHOGENETIC ASPECTS OF FORMATION OF ENDOTHELIAL DYSFUNCTION IN PREGNANT WOMEN WITH THE HISTORY OF CHRONIC ENDOMETRITIS

Taranovska O. O.

CLINICAL AND EXPERIMENTAL MEDICINE

Scentific article

The condition of the endometrium and the histological changes associated with chronic endometritis (CE) at pregnancy may be important in the formation of gestational endotheliopathy and associated preeclampsia. The aim of the research: to determine the peculiarities of the formation of gestational endotheliopathy in women whose pregnancy occurred against the background of CE and to determine the effectiveness of pre-conceptual treatment of CE in the prevention of preeclampsia. Object and methods of the research: a total of 303 women with a history of pregnancy were monitored during pregnancy, of whom 135 women received comprehensive treatment for CE (group I) at the stage of pregnancy planning. Treatment included antibacterial, anti-inflammatory and hormonal agents. The other 168 pregnant women of the mail group refused the treatment of CE in the pre-conceptual period (group II), which was documented in writing. The control group consisted of 20 healthy pregnant women with unremarkable medical history. The study included the determination of total nitrate and nitrite counts and the calculation of desquamated endothelial cells in the blood and was performed at 6-8, 16-18, and 32-34 weeks of gestation. Results. In women whose pregnancy occurred against the background of CE, at the beginning of gestation (6-8 weeks) the number of desquamated endothelial cells in the blood exceeds the control indicators by 75%; the concentration of total nitrates and nitrites at this time is not significantly different from the control values. This indicates a predominance of desquamation processes in vascular endothelium in women with CE in anamnesis. In such women, 32.1% of pregnancies were complicated by the onset of preeclampsia, with one-third being severe. In pregnant women with CE in anamnesis, the development of pre-eclampsia with moderate manifestations causes the increase of nitric oxide in the third trimester of pregnancy which is not consistent with control indicators (by 20% less), and in the case of severe preeclampsia, it critically decreases (by 46.7% less than the control indicators). This probably indicates the inability of the mechanisms of vasodilator synthesis to compensate for the increasing endotheliosis and causes the severity of clinical manifestation of preeclampsia. In women, who underwent treatment of CE in the pre-conception period, the amount of desquamated endothelial cells in the blood at 6-8 weeks of gestation is 64% less than in the untreated patients, and it corresponds to controls in healthy women. The incidence of preeclampsia is 17%, and it was severe in only 15% of these cases. The mean time at which preeclampsia occurred was 32.3 ± 0.4 weeks versus 29.4 ± 0.6 weeks in the group where women did not receive treatment for CE. Conclusions. In women whose pregnancy has occurred against the background of untreated chronic endometritis, the early stages of the gestational process create the preconditions for the formation of endotheliopathy and preeclampsia associated with it. The conducted treatment of CE for women, who are planning pregnancy, enables prevention of pre-eclampsia, especially its severe forms, at the pre-conceptual stage, and increases the duration of its clinical manifestation.

chronic endometritis, preeclampsia, endotheliopathy.

1. Lakhno I. Vplyv nespryyatlyvykh naslidkiv vahitnosti na podalʹshyy stan zdorovʺya zhinky. Z turbotoyu pro zhinku. 2019 zhovtenʹ;100(7):34-8. [in Ukrainian].
2. Romanenko TH, Sulimenko OM. Velyki akushersʹki syndromy – suchasni mozhlyvosti profilaktyky. Nealth of woman. 2018;132(5):67-72. [in Ukrainian].
3. Orlov AV, Kudinova YeI. Etiopatogeneticheskiye aspekty razvitiya platsentarnoy nedostatochnosti i zaderzhki rosta ploda. Zhurnal fundamental’noy meditsiny i biologii. 2016;176(4):4-10. [in Russian].
4. Faas MM. Vos P. Innate immune cells in the placental bed in healthy pregnancy and preeclampsia. Placenta. 2018 September;69:125-33.
5. Liu S, Diao L, Huang C, Li Y, Zeng Y, Kwak-Kimde JYH. The role of decidual immune cells on human pregnancy. Journal of Reproductive Immunology. 2017 November;124:44-53.
6. Friedman AM, Cleary KL. Prediction and prevention of ischemic placental disease. Semin. Perinatol. 2014;38(3):177-82.
7. Kerkeshko GO, Korenevskiy AV, Sokolov DI, Sel’kov SA. Rol’ vzaimodeystviya ekstrakletochnykh mikrovezikul trofoblasta s kletkami immunnoy sistemy i endoteliya v patogeneze preeklampsii. Meditsinskaya immunologiya. 2018;20(4):485-514. [in Russian].
8. Meyer N, Woidacki K, Knofler M, Meinhardt G, Nowak D, Velicky P, et al. Chymase-producing cells of the innate immune system are required for decidual vascular remodeling and fetal growth. Sci. Rep. 2017;7:451-66.
9. Romanenko TH, Sulimenko OM. Profilaktyka akushersʹkykh uskladnenʹ na tli retrokhorialʹnoyi hematomy v I trymestri vahitnosti. Ohlyad literatury. Reproduktyvna endokrynolohiya. 2018 veresenʹ;42(4):60-6. [in Ukrainian].
10. Sharma S, Godbole G, Modi D. Decidual Control of Trophoblast Invasion. Am J Reprod Immunol. 2016;75(3):341-50.
11. Galich SR, Kon’kov DG, Belkaniya GS. Klinicheskoye znacheniye gestatsionnoy endoteliopatii. Z turbotoyu pro zhínku. 2013;2:64-7. [in Russian].
12. Gomazkova OA. Molekulyarnyye i fiziologicheskiye aspekty endotelial’noy disfunktsii. Rol’ endogennykh khimicheskikh regulyatorov. Uspekhi fiziologicheskikh nauk. 2000;31(4):48-59. [in Russian].
13. Xu Y, Romero R, Miller D, Kadam L, Mial TN, Plazyo O, et al. An m1-like macrophage polarization in decidual tissue during spontaneous preterm labor that is attenuated by rosiglitazone treatment. J. Immunol. 2016;196:2476-91.
14. Faas MM, Vos P. Uterine NK cells and macrophages in pregnancy. Placenta. 2017 August;56:44-52.
15. Lash GE, Pitman H, Morgan HL, Innes BA, Agwu CN, Bulmer JN. Decidual macrophages: key regulators of vascular remodeling in human pregnancy. J. Leukoc. Biol. 2016;100:315-25.
16. Hladovec J. Circulating endothelial cells as a sign of vessel wall lesions. Phisiol. Bohemoslov. 1978 Jan;27(2):140-4.

«Bulletin of problems biology and medicine» Issue 4 Part 2 (154), 2019 year, 208-211 pages, index UDK 618.14-002-071

10.29254/2077-4214-2019-4-2-154-208-211